Unterberg Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Unterberg Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,000	Closed	-$1.11M	–	20
2018 Q2	$1.11M	Hold	12,000	–	–	1.31%	19
2018 Q1	$1.2M	Hold	12,000	–	–	1.4%	24
2017 Q4	$1.13M	Buy	+12,000	New	+$1.14M	1.38%	23

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Unterberg Capital's LKFT Position: Q3 2018 in Review

Unterberg Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2018, closing a stake of 12,000 shares — an estimated $1.11M sold.

Unterberg Capital first reported a position in LKFT in Q4 2017 and held it in 3 quarters. The position peaked at $1.2M in Q1 2018. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2018.

Unterberg Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2018 after selling out during the quarter.
Unterberg Capital sold 12,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2018, an estimated $1.11M.
Unterberg Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 3 quarters.
Unterberg Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.2M in Q1 2018.
92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2018.

Based on Unterberg Capital's 13F filing for Q3 2018, filed 24 Oct 2018.